Corrigendum to "No effect of covalently linked poly(ethylene glycol) chains on protein internal dynamics" [Biochem. Biophys. Acta 1794 (2009) 569-576] (DOI:10.1016/j.bbapap.2008.12.005);No effect of covalently linked poly(ethylene glycol) chains on protein internal dynamics

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1794, Issue 3, 2009, Pages 569-576

  Gonnelli, Margherita ^a   Strambini, Giovanni B ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

PEG; PEGylated protein; Phosphorescence; Protein dynamic

Indexed keywords

ACRYLAMIDE; ALCOHOL DEHYDROGENASE; ALKALINE PHOSPHATASE; AZURIN; MACROGOL; RIBONUCLEASE T1;

ARTICLE; CHEMICAL MODIFICATION; CHROMATOPHORE; COVALENT BOND; MOLECULAR DYNAMICS; PHOSPHORESCENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; PSEUDOMONAS AERUGINOSA;

PSEUDOMONAS AERUGINOSA;

EID: 59349115572     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2009.02.008     Document Type: Erratum

References (51)

1. Cleland J.L., and Jones A.J. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm. Res. 13 (1996) 1464-1475
2. Andrews B.A., Nielsen S., and Asenjo J.A. Partitioning and purification of monoclonal antibodies in aqueous two-phase systems. Bioseparation 6 (1996) 303-313
3. Harris D.P., Andrews A.T., Wright G., Pyle D.L., and Asenjo J.A. The application of aqueous two-phase systems to the purification of pharmaceutical proteins from transgenic sheep milk. Bioseparation 7 (1997) 31-37
4. Abuchowski A., and Davis F.F. Preparation and properties of polyethylene glycol-trypsin adducts. Biochim. Biophys. Acta 578 (1979) 41-46
5. Monkarsh S.P., Ma Y., Aglione A., Bailon P., Ciolek D., DeBarbieri B., Graves M.C., Hollfelder K., Michel H., Palleroni A., Porter J.E., Russoman E., Roy S., and Pan Y.C. Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity. Anal. Biochem. 247 (1997) 434-440
6. Esposito P., Barbero L., Caccia P., Caliceti P., D'Antonio M., Piquet G., and Veronese F.M. PEGylation of growth hormone-releasing hormone (GRF) analogues. Adv. Drug Deliv. Rev. 55 (2003) 1279-1291
7. Suzawa T., Nagamura S., Saito H., Ohta S., Hanai N., Kanazawa J., Okabe M., and Yamasaki M. Enhanced tumor cell selectivity of adriamycin-monoclonal antibody conjugate via a poly(ethylene glycol)-based cleavable linker. J. Control. Release 79 (2002) 229-242
8. Suzawa T., Nagamura S., Saito H., Ohta S., Hanai N., and Yamasaki M. Synthesis and HPLC analysis of enzymatically cleavable linker consisting of poly(ethylene glycol) and dipeptide for the development of immunoconjugate. J. Control. Release 69 (2000) 27-41
9. Suzuki T., Kanbara N., Tomono T., Hayashi N., and Shinohara I. Physicochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G. Biochim. Biophys. Acta 788 (1984) 248-255
10. Ho D.H., Brown N.S., Yen A., Holmes R., Keating M., Abuchowski A., Newman R.A., and Krakoff I.H. Clinical pharmacology of polyethylene glycol-L-asparaginase. Drug Metab. Dispos. 14 (1986) 349-352
11. Katre N.V., Knauf M.J., and Laird W.J. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 1487-1491
12. Nucci M.L., Shorr R., and Abuchowski A. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Deliv. Rev. 6 (1991) 133-151
13. Roberts M.J., Bentley M.D., and Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54 (2002) 459-476
14. Wang Y.S., Youngster S., Grace M., Bausch J., Bordens R., and Wyss D.F. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv. Drug Deliv. Rev. 54 (2002) 547-570
15. Molineux G., Kinstler O., Briddell B., Hartley C., McElroy P., Kerzic P., Sutherland W., Stoney G., Kern B., Fletcher F.A., Cohen A., Korach E., Ulich T., McNiece I., Lockbaum P., Miller-Messana M.A., Gardner S., Hunt T., and Schwab G. A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans. Exp. Hematol. 27 (1999) 1724-1734
16. Pepinsky R.B., LePage D.J., Gill A., Chakraborty A., Vaidyanathan S., Green M., Baker D.P., Whalley E., Hochman P.S., and Martin P. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity. J. Pharmacol. Exp. Ther. 297 (2001) 1059-1066
17. Greenwald R.B., Choe Y.H., McGuire J., and Conover C.D. Effective drug delivery by PEGylated drug conjugates. Adv. Drug Deliv. Rev. 55 (2003) 217-250
18. Kochendoerfer G.G., Chen S.Y., Mao F., Cressman S., Traviglia S., Shao H., Hunter C.L., Low D.W., Cagle E.N., Carnevali M., Gueriguian V., Keogh P.J., Porter H., Stratton S.M., Wiedeke M.C., Wilken J., Tang J., Levy J.J., Miranda L.P., Crnogorac M.M., Kalbag S., Botti P., Schindler-Horvat J., Savatski L., Adamson J.W., Kung A., Kent S.B., and Bradburne J.A. Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Science 299 (2003) 884-887
19. Juszczak L.J., Manjula B., Bonaventura C., Acharya S.A., and Friedman J.M. UV resonance Raman study of beta93-modified hemoglobin A: chemical modifier-specific effects and added influences of attached poly(ethylene glycol) chains. Biochemistry 41 (2002) 376-385
20. Kerwin B.A., Chang B.S., Gegg C.V., Gonnelli M., Li T., and Strambini G.B. Interactions between PEG and type I soluble tumor necrosis factor receptor: modulation by pH and by PEGylation at the N terminus. Protein Sci. 11 (2002) 1825-1833
21. Svergun D.I., Ekstrom F., Vandegriff K.D., Malavalli A., Baker D.A., Nilsson C., and Winslow R.M. Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic. Biophys. J. 94 (2008) 173-181
22. Kohen A., Cannio R., Bartolucci S., and Klinman J.P. Enzyme dynamics and hydrogen tunnelling in a thermophilic alcohol dehydrogenase. Nature 399 (1999) 496-499
23. Seymour S.L., and Klinman J.P. Comparison of rates and kinetic isotope effects using PEG-modified variants and glycoforms of glucose oxidase: the relationship of modification of the protein envelope to C-H activation and tunneling. Biochemistry 41 (2002) 8747-8758
24. Digilio G., Barbero L., Bracco C., Corpillo D., Esposito P., Piquet G., Traversa S., and Aime S. NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2. J. Am. Chem. Soc. 125 (2003) 3458-3470
25. Yamaguchi H., Suzawa T., Araki T., Kamiya M., Nemoto H., and Yamasaki M. Modification of protein with BGL06, a novel branched oligoglycerol derivative. Biochim. Biophys. Acta 1780 (2008) 680-686
26. Bhat R., and Timasheff S.N. Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols. Protein Sci. 1 (1992) 1133-1143
27. Lee J.C., and Lee L.L. Preferential solvent interactions between proteins and polyethylene glycols. J. Biol. Chem. 256 (1981) 625-631
28. Gonnelli M., and Strambini G.B. Phosphorescence lifetime of tryptophan in proteins. Biochemistry 34 (1995) 13847-13857
29. Strambini G.B., and Gonnelli M. Tryptophan phosphorescence in fluid solution. J. Am. Chem. Soc. 117 (1995) 7646-7651
30. Gonnelli M., and Strambini G.B. Intramolecular quenching of tryptophan phosphorescence in short peptides and proteins. Photochem. Photobiol. 81 (2005) 614-622
31. Cioni P., and Strambini G.B. Acrylamide quenching of protein phosphorescence as a monitor of structural fluctuations in the globular fold. J. Am. Chem. Soc. 120 (1998) 11749-11757
32. Strambini G.B., and Cioni P. Pressure-temperature effects on oxygen quenching of protein phosphorescence. J. Am. Chem. Soc. 121 (1999) 8337-8344
33. Cioni P., Piras L., and Strambini G.B. Tryptophan phosphorescence as a monitor of the structural role of metal ions in alkaline phosphatase. Eur. J. Biochem. 185 (1989) 573-579
34. Strambini G.B., and Gonnelli M. Tryptophan luminescence from liver alcohol-dehydrogenase in its complexes with coenzyme - a comparative-study of protein conformation in solution. Biochemistry 29 (1990) 196-203
35. Strambini G.B., Cioni P., and Puntoni A. Relationship between the conformation of glutamate dehydrogenase, the state of association of its subunit, and catalytic function. Biochemistry 28 (1989) 3808-3814
36. Gabellieri E., and Strambini G.B. Conformational changes in proteins induced by dynamic associations. A tryptophan phosphorescence study. Eur. J. Biochem. 221 (1994) 77-85
37. Cioni P., and Strambini G.B. Tryptophan phosphorescence and pressure effects on protein structure. Biochim. Biophys. Acta, Prot. Struct. Mol. Enzymol. 1595 (2002) 116-130
38. Gabellieri E., and Strambini G.B. Structural perturbations of azurin deposited on solid matrices as revealed by Trp phosphorescence. Biophys. J. 80 (2001) 2431-2438
39. Strambini G.B., and Gabellieri E. Proteins in frozen solutions: evidence of ice-induced partial unfolding. Biophys. J. 70 (1996) 971-976
40. Karlsson B.G., Pascher T., Nordling M., Arvidsson R.H., and Lundberg L.G. Expression of the blue copper protein azurin from Pseudomonas aeruginosa in Escherichia coli. FEBS Lett. 246 (1989) 211-217
41. Kurfurst M.M. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 200 (1992) 244-248
42. Strambini G.B., Kerwin B.A., Mason B.D., and Gonnelli M. The triplet-state lifetime of indole derivatives in aqueous solution. Photochem. Photobiol. 80 (2004) 462-470
43. Paladini Jr. A.A., and Weber G. Pressure-induced reversible dissociation of enolase. Biochemistry 20 (1981) 2587-2593
44. Sandberg A., Leckner J., and Karlsson B.G. Apo-azurin folds via an intermediate that resembles the molten-globule. Protein Sci. 13 (2004) 2628-2638
45. Vivian J.T., and Callis P.R. Mechanisms of tryptophan fluorescence shifts in proteins. Biophys. J. 80 (2001) 2093-2109
46. Hershberger M.V., Maki A.H., and Galley W.C. Phosphorescence and optically detected magnetic resonance studies of a class of anomalous tryptophan residues in globular proteins. Biochemistry 19 (1980) 2204-2209
47. Cioni P., Gabellieri E., Gonnelli M., and Strambini G.B. Heterogeneity of protein conformation in solution from the lifetime of tryptophan phosphorescence. Biophys. Chem. 52 (1994) 25-34
48. Sasahara K., and Uedaira H. Solubility of amino-acids in aqueous poly(Ethylene Glycol) solutions. Colloid Polym. Sci. 271 (1993) 1035-1041
49. Furness E.L., Ross A., Davis T.P., and King G.C. A hydrophobic interaction site for lysozyme binding to polyethylene glycol and model contact lens polymers. Biomaterials 19 (1998) 1361-1369
50. Kienberger F., Pastushenko V.P., Kada G., Gruber H.J., Riener C., Schindler H., and Hinterdorfer P. Static and dynamical properties of single poly(ethylene glycol) molecules investigated by force spectroscopy. Single Mol. 1 (2000) 123-128
51. Veronese F.M., Mero A., Caboi F., Sergi M., Marongiu C., and Pasut G. Site-specific pegylation of G-CSF by reversible denaturation. Bioconjug. Chem. 18 (2007) 1824-1830